Medpace Holdings Inc. (MEDP)
$461.60
$-5.90
(-1.26%)
As on 16-Jun-2026 16:26EDT
Market cap
$13,347 Mln
Revenue (TTM)
$2,678 Mln
P/E Ratio
29.4
P/B Ratio
22.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.8 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
21.7
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$15.7
-
Face value
--
-
Shares outstanding
28,559,689
10 Years Aggregate
CFO
$2,050.46 Mln
EBITDA
$1,684.51 Mln
Net Profit
$1,057.34 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Medpace Holdings (MEDP)
| -17.8 | 11.2 | 2.5 | 54.8 | 27.9 | 20.3 | -- |
|
BSE Sensex*
| -8.9 | 2.5 | 2.2 | -5.7 | 6.8 | 8.0 | 11.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Medpace Holdings (MEDP)
| 69.1 | 8.3 | 44.3 | -2.4 | 56.4 | 65.6 | 58.8 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Medpace Holdings (MEDP)
|
461.6 | 13,347.1 | 2,678.3 | 460.4 | 21.3 | 103.2 | 29.4 | 22.3 |
| 281.9 | 37,764.0 | 4,286.9 | 577.2 | 20.3 | 88.2 | 70.9 | 35.1 | |
| 231.2 | 14,299.5 | 867.5 | 506.6 | -0.6 | -- | 25 | 25.4 | |
| 52.1 | 13,354.5 | 2,375.5 | 833.4 | 41.5 | 40.7 | 17.6 | 6.9 | |
| 127.3 | 17,452.8 | 1,080.2 | -433.2 | -39.8 | -- | -- | 55.7 | |
| 179.2 | 29,936.9 | 16,632.0 | 1,385.0 | 14.1 | 22.3 | 22.3 | 4.9 | |
| 501.2 | 11,084.5 | 1,132.5 | -309.4 | -25.0 | -52.9 | -- | 20.4 | |
| 614.7 | 64,176.2 | 14,919.6 | 4,423.4 | 34.9 | 14.2 | 14.9 | 2.0 | |
| 548.3 | 23,174.2 | 3,169.8 | 1,287.4 | 51.3 | 20.6 | 20.2 | 3.9 | |
| 453.2 | 112,924.4 | 12,255.1 | 4,338.3 | 32.0 | 23.7 | 26.4 | 5.8 |
Shareholding Pattern
View DetailsAbout Medpace Holdings (MEDP)
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development... process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio. Read more
-
Chairman & CEO
Dr. August James Troendle M.D.
-
Chairman & CEO
Dr. August James Troendle M.D.
-
Headquarters
Cincinnati, OH
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Medpace Holdings (MEDP)
What is the current share price of Medpace Holdings Inc (MEDP) Today?
The share price of Medpace Holdings Inc (MEDP) is $461.60 (NASDAQ) as of 16-Jun-2026 16:26 EDT. Medpace Holdings Inc (MEDP) has given a return of 27.9% in the last 3 years.
What is the current PB & PE ratio of Medpace Holdings Inc (MEDP)?
The P/E ratio of Medpace Holdings Inc (MEDP) is 29.41 times as on 12-Jun-2026.
The P/B ratio of Medpace Holdings Inc (MEDP) is 22.31 times as on 12-Jun-2026, a 439 premium to its peers’ median range of 4.14 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
37.35
|
36.70
|
|
2024
|
26.29
|
12.88
|
|
2023
|
34.68
|
17.55
|
|
2022
|
29.43
|
18.69
|
|
2021
|
45.48
|
8.68
|
What is the 52 Week High and Low of Medpace Holdings Inc (MEDP)?
The 52-week high and low of Medpace Holdings Inc (MEDP) are Rs 628.92 and Rs 294.07 as of 17-Jun-2026.
What is the market cap of Medpace Holdings Inc (MEDP)?
Medpace Holdings Inc (MEDP) has a market capitalisation of $ 13,347 Mln as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Medpace Holdings Inc (MEDP)?
Before investing in Medpace Holdings Inc (MEDP), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.